KDR and cancer: Clinical studies using BR55, microbubbles targeting the endothelial biomarker vascular endothelial growth factor receptor 2 (VEGFR2), have shown their safety and usefulness for cancer detection in ovarian, breast and prostate lesions [169, 170].